MAPT and Alzheimer disease: Results from these findings highlight the impact of miR-124 on phosphorylation of tau protein through regulating PI3K/AKT/GSK-3β signaling pathway and the inhibitory effects on GSK3β, which may provide a novel therapeutic avenue in AD.